(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Viking Therapeutics, Vroom, and NASDAQ TEST STOCK.

The three biggest losers today are VerifyMe, Canaan, and Yield10 Bioscience .

Winners today

1. Viking Therapeutics (VKTX) – 123.53%

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

NASDAQ ended the session with Viking Therapeutics rising 123.53% to $86.01 on Tuesday while NASDAQ rose 0.37% to $16,035.30.

Earnings Per Share

As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.91.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.79%.

More news about Viking Therapeutics.

2. Vroom (VRM) – 36.48%

Vroom, Inc. operates an e-commerce platform for buying, selling, and trading of new and used cars in the United States. It also offers financing solutions. The company was formerly known as Auto America, Inc. and changed its name to Vroom, Inc. in July 2015. The company was founded in 2012 and is headquartered in New York, New York.

NASDAQ ended the session with Vroom rising 36.48% to $13.58 on Tuesday, after two successive sessions in a row of gains. NASDAQ jumped 0.37% to $16,035.30, after two sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Vroom has a trailing twelve months EPS of $-114.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -56.71%.

Yearly Top and Bottom Value

Vroom’s stock is valued at $13.58 at 16:32 EST, way under its 52-week high of $225.60 and way higher than its 52-week low of $8.11.

More news about Vroom.

3. NASDAQ TEST STOCK (ZWZZT) – 21.79%

NASDAQ ended the session with NASDAQ TEST STOCK rising 21.79% to $19.00 on Tuesday, after five sequential sessions in a row of losses. NASDAQ jumped 0.37% to $16,035.30, after two successive sessions in a row of losses, on what was a somewhat positive trend trading session today.

More news about NASDAQ TEST STOCK.

4. Norwegian Cruise Line (NCLH) – 19.43%

Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various locations, including destinations in Scandinavia, Russia, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. The company was founded in 1966 and is based in Miami, Florida.

NASDAQ ended the session with Norwegian Cruise Line rising 19.43% to $19.02 on Tuesday, after two sequential sessions in a row of losses. NASDAQ jumped 0.37% to $16,035.30, after two sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Norwegian cruise line (nclh) reports Q4 earnings: what key metrics have to sayHere is how Norwegian Cruise Line performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, Norwegian Cruise Line has a trailing twelve months EPS of $-0.53.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.05%.

Moving Average

Norwegian Cruise Line’s value is higher than its 50-day moving average of $17.98 and way above its 200-day moving average of $17.13.

Volatility

Norwegian Cruise Line’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.02%, a negative 0.28%, and a positive 2.08%.

Norwegian Cruise Line’s highest amplitude of average volatility was 1.01% (last week), 1.37% (last month), and 2.08% (last quarter).

Yearly Top and Bottom Value

Norwegian Cruise Line’s stock is valued at $19.02 at 16:32 EST, way below its 52-week high of $22.75 and way above its 52-week low of $12.15.

More news about Norwegian Cruise Line.

5. Plug Power (PLUG) – 18.59%

Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.

NASDAQ ended the session with Plug Power rising 18.59% to $3.61 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.37% to $16,035.30, after two successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Plug Power (plug) Q4 earnings preview: what you should know beyond the headline estimatesView all Key Company Metrics for Plug Power here>>>Shares of Plug Power have demonstrated returns of -19.8% over the past month compared to the Zacks S&P 500 composite’s +3.8% change. , In light of this perspective, let’s dive into the average estimates of certain Plug Power metrics that are commonly tracked and forecasted by Wall Street analysts.

Earnings Per Share

As for profitability, Plug Power has a trailing twelve months EPS of $-1.6.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.57%.

Sales Growth

Plug Power’s sales growth is 9% for the present quarter and 14.6% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Plug Power’s stock is considered to be overbought (>=80).

Previous days news about Plug Power

• Plug Power (plug) rises as market takes a dip: key facts. According to Zacks on Monday, 26 February, "In the latest market close, Plug Power (PLUG Quick QuotePLUG – Free Report) reached $3.04, with a +1% movement compared to the previous day. ", "The investment community will be closely monitoring the performance of Plug Power in its forthcoming earnings report. "

More news about Plug Power.

6. FibroGen (FGEN) – 12.16%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen jumping 12.16% to $2.08 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.37% to $16,035.30, after two consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.

Moving Average

FibroGen’s worth is way higher than its 50-day moving average of $1.28 and way under its 200-day moving average of $3.79.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 40% and 50.6%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 155.1%, now sitting on 154.98M for the twelve trailing months.

Volatility

FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was 0.46%, 1.44%, and 8.55%.

FibroGen’s highest amplitude of average volatility was 6.34% (last week), 11.37% (last month), and 8.55% (last quarter).

More news about FibroGen.

7. Li Auto (LI) – 11.6%

Li Auto Inc., through its subsidiaries, designs, develops, manufactures, and sells new energy vehicles in the People's Republic of China. The company provides Li ONE and Li L series smart electric vehicles. It also offers sales and after sales management, and technology development and corporate management services, as well as purchases manufacturing equipment. The company offers its products through online and offline channels. The company was formerly known as Leading Ideal Inc. and changed its name to Li Auto Inc. in July 2020. Li Auto Inc. was founded in 2015 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Li Auto jumping 11.6% to $46.13 on Tuesday while NASDAQ rose 0.37% to $16,035.30.

Earnings Per Share

As for profitability, Li Auto has a trailing twelve months EPS of $1.56.

PE Ratio

Li Auto has a trailing twelve months price to earnings ratio of 29.57. Meaning, the purchaser of the share is investing $29.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.89%.

Previous days news about Li Auto

• Nio stock forecast: Li Auto pushes EV sector higher on Monday. According to FXStreet on Monday, 26 February, "This may be because Nio is a pure EV play, while Li Auto offers a suite of hybrid vehicles.", "Nio has experienced a trying time over the past year, while Li Auto has appeared to eat its electric lunch. "

More news about Li Auto.

8. BeiGene (BGNE) – 11.31%

BeiGene, Ltd., a biotechnology company, develops and commercializes oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; Tislelizumab to treat various solid tumor and blood cancers; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; Pamiparib for the treatment of various solid tumor malignancies; and Pobevcy to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC). The company is also developing Zanubrutinib to treat B-cell malignancies; Tislelizumab, an anti-PD-1 antibody to treat solid and hematological cancers; Ociperlimab for treating solid tumors, cervical cancer, and NSCLC; Surzebiclimab, BGB-A445, BGB-15025, Lifirafenib, BGB-24714, and BGB-B167 to treat solid tumors; BGB-10188 for treating solid tumors, B-cell lymphoid malignancies, and B-cell malignancies; BGB-11417 to treat R/R chronic lymphocytic leukemia/ small lymphocytic lymphoma, R/R mantle cell lymphoma, Mature B-cell malignancies, Myeloid malignancies, and R/R multiple myeloma; BGB-16673 for B-cell malignancies; and BGB-23339 for Inflammation and immunology. The company has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., Enlivex Therapeutics Ltd., Chime Biologics Limited, and Nanjing Leads Biolabs Co., Ltd. BeiGene, Ltd. was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.

NASDAQ ended the session with BeiGene jumping 11.31% to $178.38 on Tuesday, after four sequential sessions in a row of gains. NASDAQ rose 0.37% to $16,035.30, after two sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, BeiGene has a trailing twelve months EPS of $-8.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.8%.

More news about BeiGene.

9. MicroStrategy (MSTR) – 10.86%

MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy ONE, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and MicroStrategy Cloud for Government service, which offers always-on threat monitoring that meets the rigorous technical and regulatory needs of governments and financial institutions. The company also provides MicroStrategy Support that helps customers achieve their system availability and usage goals through highly responsive troubleshooting and assistance; MicroStrategy Consulting, which provides architecture and implementation services to help customers realize their desired results; and MicroStrategy Education that offers free and paid learning options. In addition, it engages in the development of bitcoin. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.

NASDAQ ended the session with MicroStrategy jumping 10.86% to $882.96 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.37% to $16,035.30, after two successive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, MicroStrategy has a trailing twelve months EPS of $26.44.

PE Ratio

MicroStrategy has a trailing twelve months price to earnings ratio of 33.39. Meaning, the purchaser of the share is investing $33.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.17%.

Volatility

MicroStrategy’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.84%, a positive 1.53%, and a positive 3.95%.

MicroStrategy’s highest amplitude of average volatility was 4.84% (last week), 4.67% (last month), and 3.95% (last quarter).

Moving Average

MicroStrategy’s worth is way above its 50-day moving average of $581.31 and way above its 200-day moving average of $429.46.

Yearly Top and Bottom Value

MicroStrategy’s stock is valued at $882.96 at 16:32 EST, above its 52-week high of $806.78.

More news about MicroStrategy.

10. Arlington Asset Investment Corp (AI) – 10.52%

Arlington Asset Investment Corp. (NYSE: AI) is a principal investment firm that currently invests primarily in mortgage-related and other assets. The Company is headquartered in the Washington, D.C. metropolitan area. For more information, please visit www.arlingtonasset.com.

NYSE ended the session with Arlington Asset Investment Corp jumping 10.52% to $28.90 on Tuesday, following the last session’s upward trend. NYSE jumped 0.19% to $17,599.92, following the last session’s downward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Arlington Asset Investment Corp has a trailing twelve months EPS of $-2.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.13%.

Volume

Today’s last reported volume for Arlington Asset Investment Corp is 11658300 which is 33.01% above its average volume of 8764390.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Arlington Asset Investment Corp’s EBITDA is -28.48.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 366.7% and a negative 76.9%, respectively.

Moving Average

Arlington Asset Investment Corp’s value is above its 50-day moving average of $27.56 and below its 200-day moving average of $30.30.

More news about Arlington Asset Investment Corp.

Losers Today

1. VerifyMe (VRMEW) – -15%

VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.

NASDAQ ended the session with VerifyMe dropping 15% to $0.03 on Tuesday while NASDAQ jumped 0.37% to $16,035.30.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.16%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 26.3M for the twelve trailing months.

More news about VerifyMe.

2. Canaan (CAN) – -10.36%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan falling 10.36% to $1.77 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.37% to $16,035.30, after two sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.23%.

Moving Average

Canaan’s worth is under its 50-day moving average of $1.95 and way below its 200-day moving average of $2.08.

Revenue Growth

Year-on-year quarterly revenue growth declined by 75.1%, now sitting on 160.89M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be overbought (>=80).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canaan’s EBITDA is -2.22.

More news about Canaan.

3. Yield10 Bioscience (YTEN) – -6.4%

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with Yield10 Bioscience falling 6.4% to $0.24 on Tuesday, after five sequential sessions in a row of losses. NASDAQ rose 0.37% to $16,035.30, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Yield10 Bioscience has a trailing twelve months EPS of $-2.37.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -380.77%.

Yearly Top and Bottom Value

Yield10 Bioscience ‘s stock is valued at $0.24 at 16:32 EST, way below its 52-week high of $3.29 and way higher than its 52-week low of $0.18.

Sales Growth

Yield10 Bioscience ‘s sales growth for the current quarter is negative 65.5%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 58.2% and 59.2%, respectively.

More news about Yield10 Bioscience .

4. Yunji (YJ) – -6.38%

Yunji Inc. operates a social e-commerce platform in the People's Republic of China. It offers a range of product categories that cater various daily needs of users and their households, including beauty and personal care, household goods, cloths, food and fresh produce, computer and electronics, apparel, bags and cases, baby and maternity products, and home appliances. The company was founded in 2015 and is headquartered in Hangzhou, the People's Republic of China.

NASDAQ ended the session with Yunji falling 6.38% to $0.88 on Tuesday, after three sequential sessions in a row of losses. NASDAQ jumped 0.37% to $16,035.30, after two consecutive sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Yunji has a trailing twelve months EPS of $-9.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.22%.

Yearly Top and Bottom Value

Yunji’s stock is valued at $0.88 at 16:32 EST, way below its 52-week high of $5.80 and way above its 52-week low of $0.54.

Moving Average

Yunji’s worth is way above its 50-day moving average of $0.73 and way under its 200-day moving average of $1.08.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Yunji’s EBITDA is 2.01.

More news about Yunji.

5. LendingTree (TREE) – -5.4%

LendingTree, Inc., through its subsidiary, LT Intermediate Company, LLC, operates online consumer platform in the United States. It operates through three segments: Home, Consumer, and Insurance. The Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. The Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. In addition, the company offers QuoteWizard.com, a marketplace for insurance comparison; ValuePenguin, a personal finance website that offers consumers objective analysis on various financial topics from insurance to credit cards; and Stash, a consumer investing and banking platform that offers a suite of personal investment accounts, traditional and Roth IRAs, custodial investment accounts, and banking services, including checking accounts and debit cards with a Stock-Back rewards program. The company was formerly known as Tree.com, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was incorporated in 1996 and is based in Charlotte, North Carolina.

NASDAQ ended the session with LendingTree sliding 5.4% to $32.43 on Tuesday while NASDAQ jumped 0.37% to $16,035.30.

Earnings Per Share

As for profitability, LendingTree has a trailing twelve months EPS of $-11.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -94.15%.

Sales Growth

LendingTree’s sales growth is negative 32.9% for the ongoing quarter and negative 17.6% for the next.

More news about LendingTree.

6. Exagen (XGN) – -4.88%

Exagen Inc. develops and commercializes various testing products based on its Cell-Bound Complement Activation Products technology under the AVISE brand in the United States. It enable rheumatologists to enhance care for patients through the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company's products also comprise AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of eight autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE SLE Prognostic, a ten-biomarker panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Anti-CarP test, which identifies RA patients with severe disease requiring aggressive therapy, such as anti-TNF biologics; and AVISE PC4d that measures platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a six-biomarker blood test; AVISE MTX, a patented and validated blood test that measures levels of MTXPG; and AVISE HCQ, a blood test designed to help rheumatologists objectively monitor levels of hydroxychloroquine. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

NASDAQ ended the session with Exagen dropping 4.88% to $1.95 on Tuesday, following the last session’s downward trend. NASDAQ jumped 0.37% to $16,035.30, after two sequential sessions in a row of losses, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Exagen has a trailing twelve months EPS of $-1.86.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -77.6%.

More news about Exagen.

7. Upland Software (UPLD) – -4.76%

Upland Software, Inc. provides cloud-based enterprise work management software in the United States, the United Kingdom, Canada, and internationally. It offers a family of software applications under the Upland brand in the areas of marketing, sales, contact center, project management, information technology, business operations, and human resources and legal. The company also provides professional services, such as implementation, data extraction, integration and configuration, and training services, as well as customer support services. It serves large global corporations, various government agencies, and small and medium-sized businesses, as well as financial, consulting, technology, manufacturing, media, telecommunication, political, healthcare, life sciences, and retail and hospitality sectors. The company was formerly known as Silverback Enterprise Group, Inc. and changed its name to Upland Software, Inc. in November 2013. Upland Software, Inc. was incorporated in 2010 and is headquartered in Austin, Texas.

NASDAQ ended the session with Upland Software falling 4.76% to $2.60 on Tuesday, after five sequential sessions in a row of losses. NASDAQ rose 0.37% to $16,035.30, after two successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Upland Software has a trailing twelve months EPS of $-5.77.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.09%.

Moving Average

Upland Software’s worth is way under its 50-day moving average of $4.28 and way under its 200-day moving average of $3.89.

Volatility

Upland Software’s last week, last month’s, and last quarter’s current intraday variation average was a negative 21.29%, a negative 2.25%, and a positive 3.65%.

Upland Software’s highest amplitude of average volatility was 21.29% (last week), 5.31% (last month), and 3.65% (last quarter).

Volume

Today’s last reported volume for Upland Software is 410632 which is 89.06% above its average volume of 217191.

More news about Upland Software.

8. Ares Commercial Real Estate Corporation (ACRE) – -4.61%

Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, real estate preferred equity investments, mezzanine loans, and other CRE investments, including commercial mortgage backed securities. Ares Commercial Real Estate Corporation has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Management LLC operates as the manager of the company. The company was founded in 2011 and is headquartered in New York, New York.

NYSE ended the session with Ares Commercial Real Estate Corporation dropping 4.61% to $7.24 on Tuesday, after five consecutive sessions in a row of losses. NYSE rose 0.19% to $17,599.92, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Ares Commercial Real Estate Corporation has a trailing twelve months EPS of $-0.72.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.66%.

Moving Average

Ares Commercial Real Estate Corporation’s value is way below its 50-day moving average of $9.81 and way below its 200-day moving average of $9.85.

More news about Ares Commercial Real Estate Corporation.

9. Alcoa (AA) – -4.45%

Alcoa Corporation, together with its subsidiaries, produces and sells bauxite, alumina, and aluminum products in the United States, Spain, Australia, Brazil, Canada, and internationally. The company operates through three segments: Bauxite, Alumina, and Aluminum. It engages in bauxite mining operations; and processes bauxite into alumina and sells bauxite to customers who process it into industrial chemical products. The company is also involved in the aluminum smelting, casting, and rolling businesses; and the production of aluminum sheets primarily sold directly to customers in the packaging market for the production of aluminum cans. In addition, it owns hydro and coal generation assets that produce and sell electricity to the wholesale market to traders, large industrial consumers, distribution companies, and other generation companies. The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016. The company was founded in 1888 and is headquartered in Pittsburgh, Pennsylvania.

NYSE ended the session with Alcoa sliding 4.45% to $25.34 on Tuesday, after three successive sessions in a row of losses. NYSE rose 0.19% to $17,599.92, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Alcoa has a trailing twelve months EPS of $-3.65.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.43%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 78.3% and positive 137.1% for the next.

Yearly Top and Bottom Value

Alcoa’s stock is valued at $25.34 at 16:32 EST, way under its 52-week high of $55.74 and higher than its 52-week low of $23.07.

More news about Alcoa.

10. ZK International Group Co., Ltd (ZKIN) – -4.19%

ZK International Group Co., Ltd., through its subsidiaries, designs, produces, and sells double-press thin-walled stainless steel, carbon steel, and single-press tubes and fittings in the People's Republic of China. It offers steel strips, steel pipes, and light gauge stainless steel pipes, as well as pipe connections and fittings, such as couplings, adapters, unions, caps, plug pipes, elbows, three-way fittings, tees, cross, side-inlet elbows, wyes, reducers, bushings, pipe fasteners, and pipe flanges. The company also provides copper strip, valve, light industry machinery and equipment, and other stainless steel products. Its products are used in various applications, including water and gas transmission within urban infrastructural development, residential housing development, food and beverage production, oil and gas exploitation, and agricultural irrigation. The company also exports its products to Europe, Africa, and Southeast Asia. ZK International Group Co., Ltd. was founded in 2015 and is based in Wenzhou, the People's Republic of China.

NASDAQ ended the session with ZK International Group Co., Ltd sliding 4.19% to $0.69 on Tuesday while NASDAQ rose 0.37% to $16,035.30.

Earnings Per Share

As for profitability, ZK International Group Co., Ltd has a trailing twelve months EPS of $-0.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.91%.

More news about ZK International Group Co., Ltd.

Stay up to date with our winners and losers daily report